Jadakiss Bets on NY Cannabis Culture

Rapper Jadakiss is making a bold move into New York’s burgeoning cannabis industry, viewing it as the state’s next significant cultural and economic frontier. With New York’s adult-use marijuana market still finding its footing, Jadakiss is strategically positioning himself to be a key player, leveraging his influence and understanding of cultural trends to shape the…

Read More

Death Row Cannabis Lights Up Nevada Market

Death Row Records’ cannabis brand has officially launched operations in Nevada, marking a significant expansion for the music-mogul-backed enterprise. Consumers can now access a range of premium cannabis products across the Silver State, bringing the iconic Death Row brand into the burgeoning legal marijuana industry. Key Highlights: Death Row Records’ cannabis line is now available…

Read More

Cannabis Fuels 2026 Music Scene Boom

The legalization of cannabis has profoundly reshaped the music industry in 2026, fostering a more creative, collaborative, and financially robust environment for artists and fans alike. From altered studio sessions to new revenue streams, the plant’s presence is now deeply interwoven with the sound and business of music. Key Highlights: Enhanced Creative Processes: Many artists…

Read More

Steppin’ Razor’s ‘Labyrinth Books’ Album Drops

Steppin’ Razor has officially released their highly anticipated album, “Labyrinth Books,” marking a significant moment in their evolving discography. The album, a collection of intricate lyrical narratives and genre-bending soundscapes, has been met with immediate buzz from fans and critics alike. “Labyrinth Books” promises to be a defining work for the artist, delving into complex…

Read More

Nevada Cannabis: Federal Rescheduling Rewrites the Future

The federal government has executed its most significant maneuver in drug policy since the Controlled Substances Act of 1970. On April 23, 2026, the U.S. Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) finalized an order reclassifying state-licensed medical marijuana products—alongside FDA-approved cannabis drugs—from Schedule I to Schedule III. For Nevada’s robust cannabis…

Read More